BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: McCain S, Trainor J, McManus DT, McMenamin ÚC, McQuaid S, Bingham V, James JA, Salto-Tellez M, Turkington RC, Coleman HG. Vitamin D receptor as a marker of prognosis in oesophageal adenocarcinoma: a prospective cohort study. Oncotarget 2018;9:34347-56. [PMID: 30344947 DOI: 10.18632/oncotarget.26151] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Conway C, Collins DM, McCann A, Dean K. Research Strategies for Low-Survival Cancers. Cancers (Basel) 2021;13:528. [PMID: 33573275 DOI: 10.3390/cancers13030528] [Reference Citation Analysis]
2 Loehrer E, Betensky RA, Giovannucci E, Su L, Shafer A, Hollis BW, Christiani DC. Serum Levels of 25-Hydroxyvitamin D at Diagnosis Are Not Associated with Overall Survival in Esophageal Adenocarcinoma. Cancer Epidemiol Biomarkers Prev 2019;28:1379-87. [PMID: 31186263 DOI: 10.1158/1055-9965.EPI-18-1190] [Reference Citation Analysis]